Find a Tender
complete
Official procurement procedure
Next Generation Sequencing Panel for Analysis of Somatic (Solid Tumour and Haemato-oncology) Samples
Laboratory reagents
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Wales Shared Services Partnership on behalf of Cardiff and Vale University Local Health Board: "Next Generation Sequencing Panel for Analysis of Somatic (Solid Tumour and Haemato-oncology) Samples". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS Wales Shared Services Partnership on behalf of Cardiff and Vale University Local Health Board | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: NHS Wales Shared Services Partnership on behalf of Cardiff and Vale University Local Health Board
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS Wales Shared Services Partnership on behalf of Cardiff and Vale University Local Health Board. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
2Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 1 active published awards; 1 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published12 May 2021, 16:34 BST | Last source update12 May 2021, 16:34 BST | Recurring procurementNot published |
ClassificationLaboratory reagents | ||
Delivery area | ||
OCIDocds-h6vhtk-02b04b | ||
What is being bought
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) on behalf of Cardiff and Vale University Health Board are looking to procurement a somatic NGS testing platform with a single workflow for both DNA and RNA library preparation. It must be a targeted panel of at least 500 genes for the DNA component and 50 genes for the RNA component which are of clinical relevance to comprehensive cancer genomic profiling (including both current and future clinically actionable genes and those associated with clinical trials).
What changed
From the official release history
- Status changed to complete
12 May 2021, 16:34 BST - Official notice release published
12 May 2021, 16:34 BST - Buyer information updated
12 May 2021, 16:34 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedThe All Wales Medical Genomics Laboratory (AWMGL) recently received an uplift in funding to enable the delivery of equitable testing for patients in Wales to patients in England who are eligible for tests detailed in the Genomics England National Genomics Test Directory for Cancer, thus, supporting AWMGL to work with Welsh clinicians to align services to the Test Directory. To enable successful alignment it is essential that the laboratory expands their services that are offered to those that are indicated as essential services in the Genomics England National Genomics Test Directory for Cancer 2020/2021 (https://www.england.nhs.uk/publication/national-genomic-test-directories/). To meet the service needs, AWMGL are looking to purchase a new DNA and RNA based single targeted somatic testing panel of at least 500 genes of clinical relevance to comprehensive cancer genomic profiling (including both current and future clinically actionable genes and those associated with clinical trials).Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
12 May 2021, 16:34 BST - Award active
Not published · Not published - Contract active
Signed 16 Mar 2021, 00:00 GMT · £10,768,696
Commercial outcome and competition
Awards Illumina Cambridge Ltd Not published · Not published · active |
Contracts Contract £10,768,696 · signed 16 Mar 2021, 00:00 GMT · active |
Bid statistics bids: 2 (lot 1) electronicBids: 2 (lot 1) foreignBidsFromEU: 2 (lot 1) foreignBidsFromNonEU: 0 (lot 1) smeBids: 0 (lot 1) |
Buyer and organisations in this procedure
NHS Wales Shared Services Partnership on behalf of Cardiff and Vale University Local Health Board
Contracting authority GB-FTS-16030Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published